Brian Sun

Brian Sun is an experienced legal professional currently serving as the Senior Vice President, Chief Legal Officer, and Corporate Secretary at Avenzo Therapeutics since August 2022. Sun has a notable career in the biotechnology and therapeutic sectors, with previous roles including Senior Vice President, General Counsel, and Corporate Secretary at Turning Point Therapeutics until its acquisition by Bristol Myers Squibb in August 2022, and Sorrento Therapeutics from 2018 to 2022. Additionally, Sun served as the Director of Intellectual Property at Prometheus Laboratories, and in various attorney positions at Hologic, Foley & Lardner LLP, Gordon Rees Scully Mansukhani, and Nath, Goldberg & Meyer. Sun holds a J.D. from the University of San Diego School of Law, an M.S. in Biotechnology from The Johns Hopkins University, and a B.A. in Molecular and Cell Biology with an English minor from the University of California, Berkeley.